GILEAD SCIENCES INC (GILD:NASDAQ)
$135.63 3.93 (2.9841%)
Analysed GILEAD SCIENCES INC (GILD:NASDAQ) News Sources
Is Gilead Sciences (GILD) Cheap With Trodelvy And Yeztugo In Focus?
09-07-2026
yahoo.com
2 Recession-Resistant Dividend Stocks to Buy and Hold
10-07-2026
fool.com
Gilead Sciences (GILD) Stock Dips While Market Gains: Key Facts
10-07-2026
yahoo.com
Many Investors Are Still Treating Gilead Sciences Like a Has-Been HIV Stock. 4 Drug Launches This Year Could Prove Them Wrong.
12-07-2026
fool.com
Own Regeneron For Biotech Growth? Incyte Is Making Its Case.
13-07-2026
trefis.com
Spotting Winners: Gilead Sciences (NASDAQ:GILD) And Therapeutics Stocks In Q1
14-07-2026
yahoo.com
Is the Bearishness Around Pfizer and Gilead Sciences a Contrarian Opportunity?
15-07-2026
247wallst.com
Kalshi Will Offer Sports-Style Betting on Drug Trial Results
16-07-2026
yahoo.com
Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know
16-07-2026
yahoo.com
Kalshi Allows Betting On Clinical Trials And FDA Drug Decisions
16-07-2026
cryptoprowl.com
What is the current price of GILEAD SCIENCES INC (GILD:NASDAQ)?
The current price of GILEAD SCIENCES INC (GILD:NASDAQ) is $135.63.
GILEAD SCIENCES INC (GILD:NASDAQ) absolute price change since previous trading day?
The absolute price change of GILEAD SCIENCES INC (GILD:NASDAQ) since the previous trading day is $3.93.
GILEAD SCIENCES INC (GILD:NASDAQ) percentage price change since previous trading day?
The percentage price change of GILEAD SCIENCES INC (GILD:NASDAQ) since the previous trading day is 2.9841%.
What is the most recent average sentiment score for GILEAD SCIENCES INC (GILD:NASDAQ)?
The most recent average sentiment score for GILEAD SCIENCES INC (GILD:NASDAQ) is 82 out of 100.
What is the most recent average sentiment for GILEAD SCIENCES INC (GILD:NASDAQ)?
The most recent sentiment for GILEAD SCIENCES INC (GILD:NASDAQ) is .
SEC-8K** Filing Available For GILEAD SCIENCES INC (GILD:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.